X

API Facility 

Our Cutting-edge API Manufacturing Facility

At Concord, our API manufacturing facility is pivotal in the fermentation-based API market. With over 25 years of expertise, we excel in manufacturing high-quality fermentation based APIs. Our state-of-the-art facility is adept at selecting and producing molecules in key therapeutic areas, ensuring consistent development and reliability. This robust capability strengthen our position as an industry leader.
Explore R&D Excellence 

Where Precision
Powers Every Dose 

Unit 1  

A Foundation 

This facility marked the beginning of our journey, dedicated to producing high-quality APIs and advancing healthcare excellence.Dholka, Gujarat | India 
Explore More
Unit 3

A Mega Pharma Hub 

As one of the largest fermentation based API unit, we drive advanced pharmaceutical manufacturing with innovative technology and exceptional quality.Limbasi, Gujarat | India
Explore More

Manufacturing & Infrastructure Capabilities 

Robust Manufacturing Infrastructure 

We operate two state-of-the-art API manufacturing facilities in India, with a combined fermentation capacity of 1,250 M3.  

Integrated Platform

Our comprehensive platform encompasses R&D, patents, manufacturing, and marketing capabilities.

Backward Integration 

We reduce costs, increase quality control, and streamline the production process in our backward integration plant.  

Capacity for Future Growth 

With robust utilization and expansion capability, we are well positioned to capitalize on emerging opportunities in the future. 

Regulatories

Our API units have been inspected by the USFDA and hold key regulatory approvals from EU GMP, Japanese AFM, Korean FDA, State GMP, DSIR (India), ANVISA (Brazil), and EU regulatory authority (Bavaria, Germany).

Crafting API Excellence at
Every Stage

Microbiological Laboratory 

Concord Biotech has a modern microbiology lab with skilled microbiologists following strict guidelines. The lab handles microorganisms, supplies inoculum to the plant, and performs quality checks. It meets biosafety level 2 standards and follows international safety protocols. 

Fermentation  

Our API facility has multiple fermentation blocks with fermenters ranging from 5 m³ to 30 m³, totaling over 1250 m³ in capacity. These are supported by seed fermenters and dosing vessels. Inoculum preparation is handled by a dedicated facility, and the entire process is monitored by an automated control system, overseen by microbiologists, biochemical engineers, and chemists.

Downstream Recovery  

Our downstream recovery facilities support our fermentation processes. We have multiple recovery blocks for various products like immunosuppressants, oncology, anti-infectives, antifungals, and enzymes. Key equipment includes whole broth extractors, various filtration systems, high-pressure homogenizers, chromatography columns, commercial-scale preparative-HPLC, an oncology facility with isolators, hydrogenation units, a lyophilization block, SS-316 and GLR reactors, and different drying equipment like RCVD, vacuum tray dryers, and fluid bed processors.

Powder Processing Area  

Our powder processing area is equipped with air handling systems that meet Class 100,000 standards. Key equipment includes HVAC systems, crystallizers, micronizers for milling and sieving, and various drying equipment such as RCVD, VTD, FBD, and freeze drying units.

Safety, Health &
Environment 

As an environmentally conscious organization, Concord Biotech Limited is committed to sustainable practices, including efficient environmental management and preservation methods. We maintain a state-of-the-art facility for treating effluents, fully complying with statutory regulations. Additionally, we prioritize the health and safety of our employees through regular medical check-ups and awareness programs to prevent work-related hazards.